Citanest

Active Ingredient(s): Prilocaine
FDA Approved: * November 18, 1965
Pharm Company: * ASTRAZENECA
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Citanest Overview

Prilocaine (/pralken/[1]) is a local anesthetic of the amino amide type first prepared by Claes Tegner and Nils Löfgren. In its injectable form (trade name Citanest), it is often used in dentistry. It is also often combined with lidocaine as a topical preparation for dermal anesthesia (lidocaine/prilocaine or EMLA), for treatment of conditions like paresthesia. As it has low cardiac toxicity, it is commonly used for intravenous regional anaesthesia (IVRA). Contents ...

Read more Citanest Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Prilocaine

Recent Citanest Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Prilocaine
  • Injection: 0.005mg/ml + 4%, 1%, 2%, 3%, 4%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Prilocaine or a similar ingredient: (6 results)

Related Citanest Topics:

Citanest 4% injection
Does Citanest 4% have sulf?...